Teriflunomide-induced Palmoplantar Lichenoid Eruption: A Case Report
DOI:
https://doi.org/10.2340/actadv.v104.40967Keywords:
lichenoid drug eruption, teriflunomide, multiple sclerosis, adverse reactionAbstract
Abstract is missing (Short communication)
Downloads
References
Agharbi FZ, Aasfara J, Oqbani K, Slamti K, Chiheb S. Lichenoid drug eruption induced by teriflunomide. Ann Indian Acad Neurol 2023; 26: 275-277.
https://doi.org/10.4103/aian.aian_27_23 DOI: https://doi.org/10.4103/aian.aian_27_23
Paolino G, Rongioletti F. Palmoplantar lichenoid drug eruptionfollowing the administration of Pfizer-BioNTech COVID-19 vaccine. JAAD Case Rep 2022; 21: 182-184.
https://doi.org/10.1016/j.jdcr.2022.01.014 DOI: https://doi.org/10.1016/j.jdcr.2022.01.014
Musicante M, Goenaga-Vázquez Y, Klimas N. Lichenoid drug eruption induced by erenumab. JAAD Case Rep 2023; 32: 26-28.
https://doi.org/10.1016/j.jdcr.2022.11.018 DOI: https://doi.org/10.1016/j.jdcr.2022.11.018
Khurana D, Kaur G, Kumaran MS, Choudhary R, Ashraf R, Thakur V. Teriflunomide-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Exp Dermatol 2021; 46: 166–169
https://doi.org/10.1111/ced.14339 DOI: https://doi.org/10.1111/ced.14339
Arslan D, Aksakal AB, Erdem Ö, Tuncer MA. A case of drug-induced bullous pemphigoid associated with teriflunomide: a patient with relapsing multiple sclerosis. Mult Scler Relat Disord 2020; 43: 102157.
https://doi.org/10.1016/j.msard.2020.102157 DOI: https://doi.org/10.1016/j.msard.2020.102157
Published
How to Cite
License
Copyright (c) 2024 Gökçe Işıl Kurmuş, Şükran Cansu Tiryaki Buyruk, Dilek Menteşoğlu, Selda Pelin Kartal, Murat Alper
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
